COVID-19: Salvage TOcilizumab as a Rescue Measure

Status:
Completed

Trial end date:
2021-06-16

Target enrollment:

Participant gender:

Evaluating the efficacy of Tocilizumab in hospitalized patients in the inflammatory phase of COVID-19. Randomization 2:1 (TCZ:standard of care).

Phase 3

Jarmo Oksi